Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Marsh

Showing results (181-190 of 337) with videos related to

Pageof 34
Sort By:
Vaccine|August 23, 2005
High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal KenyaSpencer D Polley, David J Conway, David R Cavanagh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2006
Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in KenyaPhilip Bejon, Norbert Peshu, Sarah C Gilbert, et al.
Infection and Immunity|July 31, 2013
Analysis of antibodies to newly described Plasmodium falciparum merozoite antigens supports MSPDBL2 as a predicted target of naturally acquired immunityKevin K A Tetteh, Faith H A Osier, Ali Salanti, et al.
Plos One|August 22, 2007
Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in KenyaPhilip Bejon, Edna Ogada, Tabitha Mwangi, et al.
Molecular Microbiology|April 25, 2008
Plasmodium falciparum antigenic variation. Mapping mosaic var gene sequences onto a network of shared, highly polymorphic sequence blocksPeter C Bull, Caroline O Buckee, Sue Kyes, et al.
European Journal of Public Health|September 7, 2010
Exploring the role of economics in prioritization in public health: what do stakeholders think?Ceri J Phillips, Richard Fordham, Kevin Marsh, et al.
The Journal of Infectious Diseases|July 10, 2004
Iron deficiency and malaria among children living on the coast of KenyaAlice M Nyakeriga, Marita Troye-Blomberg, Jeffrey R Dorfman, et al.
Plos One|May 15, 2009
Prospective identification of malaria parasite genes under balancing selectionKevin K A Tetteh, Lindsay B Stewart, Lynette Isabella Ochola, et al.
Vaccine|April 20, 2006
Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic areaPhilip Bejon, Jedidah Mwacharo, Oscar K Kai, et al.
Plos One|February 19, 2013
Plasmodium falciparum infection patterns since birth and risk of severe malaria: a nested case-control study in children on the coast of KenyaKlara Lundblom, Linda Murungi, Victoria Nyaga, et al.
Pageof 34

Showing results (181-190 of 337) with videos related to

Sort By:
Pageof 34
Vaccine|August 23, 2005
High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal KenyaSpencer D Polley, David J Conway, David R Cavanagh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2006
Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in KenyaPhilip Bejon, Norbert Peshu, Sarah C Gilbert, et al.
Infection and Immunity|July 31, 2013
Analysis of antibodies to newly described Plasmodium falciparum merozoite antigens supports MSPDBL2 as a predicted target of naturally acquired immunityKevin K A Tetteh, Faith H A Osier, Ali Salanti, et al.
Plos One|August 22, 2007
Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in KenyaPhilip Bejon, Edna Ogada, Tabitha Mwangi, et al.
Molecular Microbiology|April 25, 2008
Plasmodium falciparum antigenic variation. Mapping mosaic var gene sequences onto a network of shared, highly polymorphic sequence blocksPeter C Bull, Caroline O Buckee, Sue Kyes, et al.
European Journal of Public Health|September 7, 2010
Exploring the role of economics in prioritization in public health: what do stakeholders think?Ceri J Phillips, Richard Fordham, Kevin Marsh, et al.
The Journal of Infectious Diseases|July 10, 2004
Iron deficiency and malaria among children living on the coast of KenyaAlice M Nyakeriga, Marita Troye-Blomberg, Jeffrey R Dorfman, et al.
Plos One|May 15, 2009
Prospective identification of malaria parasite genes under balancing selectionKevin K A Tetteh, Lindsay B Stewart, Lynette Isabella Ochola, et al.
Vaccine|April 20, 2006
Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic areaPhilip Bejon, Jedidah Mwacharo, Oscar K Kai, et al.
Plos One|February 19, 2013
Plasmodium falciparum infection patterns since birth and risk of severe malaria: a nested case-control study in children on the coast of KenyaKlara Lundblom, Linda Murungi, Victoria Nyaga, et al.
Pageof 34